EUVIMEDEUVIMED entdecken
Crossref

Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran

Mohadeseh Sheykhi-Sabzehpoush iD, Ali Khodadadi, Moosa Sharifat, Maryam Haddadzadeh Shoushtari, Hanieh Raji, Ata A Ghadiri

Genetic Testing and Molecular Biomarkers · 2025

DOI: 10.1089/gtmb.2025.0075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, 2025. Verfasst von Mohadeseh Sheykhi-Sabzehpoush und 5 weiteren Autor:innen. Beteiligte Einrichtung: Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: COVID-19, Interleukin-6. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Genetic predisposition is an important factor related to the enhancement of inflammation or immune responses in COVID-19 patients. This study aimed to explore the association between the IL-6 (rs1800795) polymorphism and COVID-19 severity in the southwest of Iran.

Methods

We evaluated these variants in 100 patients with moderate and 100 patients with severe COVID-19 using an (Amplification Refractory Mutation System Polymerase Chain Reaction) ARMS-PCR assay. In addition, we collected clinical characteristics of patients to assess their association with the severity of COVID-19. Statistically, the significance in the present evaluation was p < 0.05.

Results

Our findings showed a significant association with the SNP-174G/C of the IL-6 gene between the moderate and severe groups of COVID-19 patients under the dominant and codominant genetic models (p = 0.02 and 0.03, respectively). The frequency of the G allele was notably higher in the severe group compared to the moderate group (p = 0.02). Also, the rs1800795 genotypes, as well as the patients' age and gender (p = 0.13 and 0.31, respectively), were detected. Additionally, we confirmed a significant correlation between clinical data known as risk factors for COVID-19 severity.

Conclusion

Taken together, understanding the risk factors associated with the increased severity of COVID-19 may provide the opportunity for early and useful intervention in individuals at higher risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Interleukin-6HumansIranFemaleMalePolymorphism, Single NucleotideMiddle AgedGenetic Predisposition to DiseaseSeverity of Illness IndexSARS-CoV-2AdultGene FrequencyGenotypeAgedAlleles

Stichwörter der Autor:innen

COVID-19IL-6clinical datageneticpolymorphismrisk factor

Substanzen

Interleukin-6IL6 protein, human

Autor:innen und Institutionen

  • Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

ORCID-Profile: Mohadeseh Sheykhi-Sabzehpoush

Zitieren

APA

Sheykhi-Sabzehpoush, M., Khodadadi, A., Sharifat, M., Haddadzadeh Shoushtari, M., Raji, H., & Ghadiri, A. A. (2025). Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran. Genetic Testing and Molecular Biomarkers. https://doi.org/10.1089/gtmb.2025.0075

Vancouver

Sheykhi-Sabzehpoush M, Khodadadi A, Sharifat M, Haddadzadeh Shoushtari M, Raji H, Ghadiri AA. Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran. Genetic Testing and Molecular Biomarkers. 2025. doi:10.1089/gtmb.2025.0075

BibTeX
@article{SheykhiSabzehpoush2025,
  author = {Sheykhi-Sabzehpoush, Mohadeseh and Khodadadi, Ali and Sharifat, Moosa and Haddadzadeh Shoushtari, Maryam and Raji, Hanieh and Ghadiri, Ata A},
  title = {Significant Association of Interleukin-6 Polymorphism and Clinical Data with COVID-19 Severity in the Southwest of Iran},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2025},
  doi = {10.1089/gtmb.2025.0075}
}
Kostenlos starten →